Last: | $40.235 |
---|---|
Change Percent: | 0.01% |
Open: | $40.21 |
Close: | $40.23 |
High: | $40.42 |
Low: | $39.965 |
Volume: | 1,183,431 |
Last Trade Date Time: | 04/26/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$40.235 | $40.21 | $40.23 | $40.42 | $39.965 | 1,183,431 | 04-26-2024 |
$40.23 | $40.75 | $40.23 | $40.79 | $39.765 | 3,565,784 | 04-25-2024 |
$40.93 | $40.78 | $40.93 | $41.06 | $40.54 | 2,134,295 | 04-24-2024 |
$41.02 | $40.4 | $41.02 | $41.18 | $40.25 | 2,646,343 | 04-23-2024 |
$40.4 | $39.78 | $40.4 | $40.82 | $39.525 | 3,272,883 | 04-22-2024 |
$39.47 | $39.93 | $39.47 | $40.08 | $39.39 | 2,808,386 | 04-19-2024 |
$39.65 | $39.74 | $39.65 | $39.74 | $39.29 | 2,332,137 | 04-18-2024 |
$39.52 | $39.71 | $39.52 | $39.845 | $39.46 | 2,809,448 | 04-17-2024 |
$39.57 | $40 | $39.57 | $40.05 | $39.35 | 2,658,887 | 04-16-2024 |
$40.04 | $40.71 | $40.04 | $40.85 | $39.815 | 3,062,144 | 04-15-2024 |
$40.33 | $41.74 | $40.33 | $41.9 | $40.205 | 4,126,975 | 04-12-2024 |
$42.12 | $42.44 | $42.12 | $42.475 | $41.69 | 3,060,574 | 04-11-2024 |
$42 | $42.24 | $42 | $42.265 | $41.33 | 3,615,357 | 04-10-2024 |
$42.83 | $42.41 | $42.83 | $42.86 | $42.17 | 2,772,997 | 04-09-2024 |
$42.25 | $42.55 | $42.25 | $42.78 | $42.1 | 2,397,943 | 04-08-2024 |
$42.62 | $42.45 | $42.62 | $42.8 | $42.38 | 2,970,219 | 04-05-2024 |
$42.63 | $43.58 | $42.63 | $43.7 | $42.375 | 3,126,278 | 04-04-2024 |
$43.28 | $42.96 | $43.28 | $43.715 | $42.75 | 2,544,668 | 04-03-2024 |
$42.91 | $42.98 | $42.91 | $43.31 | $42.68 | 2,900,712 | 04-02-2024 |
$43.55 | $43.5 | $43.55 | $43.99 | $43.05 | 4,552,665 | 04-01-2024 |
News, Short Squeeze, Breakout and More Instantly...
Baxter International Inc. Company Name:
BAX Stock Symbol:
NYSE Market:
Baxter International Inc. Website:
Five new launches reinforce Baxter’s focus on differentiated products and enhance the company’s Pharmaceuticals portfolio in critical therapeutic areas Products feature ready-to-use formulations to help support patient safety and offer added convenience for healthcare profession...
Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its first-quarter 2024 financial results on Thursday, May 2, 2024 at 7:30 a.m. Central Time. To participate in this conference call please follow this link https://registrations.events/direct/Q...